Related Experiment Video
Updated: Jan 16, 2026

Evaluation of Capillary and Other Vessel Contribution to Macular Perfusion Density Measured with Optical Coherence Tomography Angiography
Published on: February 18, 2022
Choroidal Vascularity Index Changes in Treatment-Naïve Hypercholesterolemia Patients
Zeynep Eylul Ercan1, Mucahit Yetim2, Selim Cevher3
1Department of Ophthalmology, Yenimahalle Education and Training Hospital, Yildirim Beyazit University, Ankara, Turkey.
Insights
Newly diagnosed hypercholesterolemia patients show a lower choroidal vascularity index (CVI) and thicker stromal area compared to healthy individuals. Lipid levels did not correlate with CVI in this study.
Area of Science:
- Ophthalmology
- Cardiovascular Health
- Medical Imaging
Background:
- Hypercholesterolemia is a significant risk factor for cardiovascular disease.
- Choroidal vascularity index (CVI) is a measure of vascular status in the choroid.
- The impact of hypercholesterolemia on choroidal vascularity is not well understood.
Purpose of the Study:
- To investigate the choroidal vascularity index (CVI) in newly diagnosed hypercholesterolemia patients.
- To compare CVI between hypercholesterolemia patients and healthy controls.
- To explore the relationship between lipid levels and CVI.
Main Methods:
- Cross-sectional study comparing 50 hypercholesterolemia patients and 50 controls.
- Analysis of choroidal vascularity index (CVI), total choroidal area (TCA), luminal area (LA), and stromal area (SA).
- Statistical analysis included analysis of covariance and partial correlation, adjusting for age, sex, and axial length.
Main Results:
- Choroidal vascularity index (CVI) was significantly lower in hypercholesterolemia patients (P < 0.001).
- Stromal area (SA) was significantly thicker in patients (P = 0.006), while TCA and LA showed no significant differences.
- No correlation was found between lipid levels and CVI.
Conclusions:
- Hypercholesterolemia is associated with a reduced CVI and increased stromal area in the choroid.
- The observed changes in stromal area did not affect overall choroidal area or luminal area.
- Further research with longer follow-up is needed to elucidate the effects of increased stromal area.
Purpose:
To measure the choroidal vascularity index (CVI) in newly diagnosed hypercholesterolemia patients.
Methods:
This cross-sectional study included 50 treatment-naïve hypercholesterolemia patients and 50 age-matched healthy controls. None of the patients had other systemic diseases. CVI in the patient and control groups was compared. In addition, the effect of lipid levels on CVI was calculated. Analysis of covariance was used to compare groups after adjusting for axial length, age, and sex. The partial correlation coefficient was determined for the correlation between lipid levels and choroidal area in both groups. The level of statistical significance was set at P < 0.05.
Results:
CVI was significantly lower in the study group (<0.001). There were no differences in total choroidal area (TCA) (P = 0.141) or luminal area (LA) (P = 0.539) between the groups. The stromal area (SA) was, however, significantly thicker in the patient group than in the control group (P = 0.006). Lipid levels and CVI were not correlated.
Conclusions:
The present findings show that hypercholesterolemia patients have a significantly thicker SA and a lower CVI than healthy controls. Interestingly, the increased stromal are in the patients did not result in an increase in the TCA or compressed vascular tissues that would have presented as a reduction in LA. The present findings should be considered preliminary, and additional studies with longer follow-ups may further clarify the effects of increased SA thickness.
More Related Videos
10:24Detecting Abnormalities in Choroidal Vasculature in a Mouse Model of Age-related Macular Degeneration by Time-course Indocyanine Green Angiography
Published on: February 19, 2014
12:28Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies
Published on: March 12, 2022
Related Concept Videos
Atherosclerosis III: Management
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Cholesterol: Significance and Regulation
Considering cholesterol and...
Acute Coronary Syndrome III: Diagnostic Studies
Angle Closure Glaucoma: Treatment